PT-141 is a prescription medication with an approved use; the reproductive-axis peptides act on the hormone system and belong in a clinical context. This is not an area for casual experimentation.
Peptides researched for this goal
A melanocortin agonist approved for certain forms of low sexual desire.
A hypothalamic peptide studied for its role in reproductive hormone signaling.
A synthetic form of GnRH used to stimulate pituitary hormone release.
A melanocortin agonist studied for skin pigmentation.
Frequently asked questions
PT-141 (bremelanotide) is the main one, and it is FDA-approved for hypoactive sexual desire disorder in certain populations. It acts on arousal pathways rather than blood flow.
PT-141 is a prescription medication that can affect blood pressure and cause nausea; it requires medical supervision. The reproductive-axis peptides are hormone-active.
Get a stack matched to your goals
Describe your situation and Selpho's free AI advisor will suggest research-backed peptides — no signup needed.
Try the Peptide AdvisorThis page is for educational purposes only and is not medical advice, a diagnosis, or a recommendation to use any compound. It contains no dosing or purchase information. Always consult a licensed healthcare professional before considering any peptide.